Kenyataan Media
AMENDED PN17: IMPOSITION OF TRADING SUSPENSION AND COMMENCEMENT OF DE-LISTING PROCEDURES AGAINST LIQUA HEALTH CORPORATION BERHAD
Bursa Malaysia Securities Berhad ("Bursa Securities") would like to announce that the trading of the securities of Liqua Health Corporation Berhad ("LIQUA" or "the Company"), an Amended Practice Note No. 17/2005 ("Amended PN17") company will be suspended with effect from 9.00 am, Wednesday, 31 December 2008pursuant to paragraph 8.14C(4) of the Listing Requirements of Bursa Securities ("LR").
LIQUA has failed to submit its regularisation plan to the Securities Commission and other relevant authorities for approval within the timeframe stipulated by Bursa Securities pursuant to paragraph 8.14C of the LR and paragraph 4.0 of PN17 ie. on or before 22 December 2008.
In addition to the imposition of suspension, Bursa Securities has commenced de-listing procedures against the Company. The Company has been served with a notice by Bursa Securities today to make representations to Bursa Securities as to why the Company's securities should not be de-listed from the Official List of Bursa Securities. Due process is therefore accorded to the Company prior to making a decision on whether to de-list the Company's securities from the Official List of Bursa Securities.
Upon due consideration of the matter and the conclusion of the relevant due process accorded, Bursa Securities will decide whether to de-list the Company. Where a decision is made to de-list the Company, the Company shall be notified of the same accordingly. Upon receipt of the notification of the decision by Bursa Securities to de-list the Company's securities from the Official List of Bursa Securities, the Company shall be required to make an immediate announcement. Thereafter, the securities of the Company shall be removed from the Official List of Bursa Securities on a date specified by Bursa Securities.